Last reviewed · How we verify
Dexamethasone nanoparticles eye drops
Glucocorticoid receptor agonist
Glucocorticoid receptor agonist Used for Uveitis.
At a glance
| Generic name | Dexamethasone nanoparticles eye drops |
|---|---|
| Sponsor | Oculis |
| Drug class | Glucocorticoid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 2 |
Mechanism of action
Dexamethasone acts as a synthetic glucocorticoid receptor agonist, which reduces inflammation and immune responses.
Approved indications
- Uveitis
Common side effects
- Increased intraocular pressure
- Eye pain
- Blurred vision
Key clinical trials
- OCS-01 in Treating Inflammation and Pain in Post-cataract Patients (PHASE2)
- Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |